Lassere MN: The biomarker-surrogacy evaluation schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints. Stat Methods Med Res. 2008, 17: 303-340.
Article
PubMed
Google Scholar
Committee on Qualification of Biomarkers and Surrogate Endpoints: Evaluation of biomarkers and surrogate endpoints in chronic disease. Appendix A. 2010, Washington: The National Academies Press, IOM (Institute of Medicine) DC; 2010
Google Scholar
Boissel JP, Collet JP, Moleur P, Haugh M: Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol. 1992, 43: 235-244. 10.1007/BF02333016.
Article
CAS
PubMed
Google Scholar
Lassere MN, Johnson KR, Boers M, Tugwell P, Brooks P, Simon L, Strand V, Conaghan PG, Ostergaard M, Maksymowych WP, Landewe R, Bresnihan B, Tak PP, Wakefield R, Mease P, Bingham CO, Hughes M, Altman D, Buyse M, Galbraith S, Wells G: Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. J Rheumatol. 2007, 34: 607-615.
PubMed
Google Scholar
Lassere MN: The Innovative Evaluation Schema of Validating Putative Surrogate Endpoints. Joint Statistical Meetings. Vancouver, Canada, [http://www.amstat.org/meetings/jsm/2010/onlineprogram/AbstractDetails.cfm?abstractid=306921]
Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H: The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostat. 2000, 1: 49-67. 10.1093/biostatistics/1.1.49.
Article
Google Scholar
The evaluation of surrogate endpoints. Springer Science+Business Media Inc. Edited by: Burzykowski T, Molenberghs G, Buyse M. 2005
Daniels MJ, Hughes MD: Meta-analysis for the evaluation of potential surrogate markers. Stat Med. 1997, 16: 1965-1982. 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M.
Article
CAS
PubMed
Google Scholar
Burzykowski T, Buyse M: Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validation. Pharmaceut Statist. 2006, 5: 173-186. 10.1002/pst.207.
Article
Google Scholar
Johnson K, Ringland C, Stokes B: Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncology. 2006, 7: 741-746. 10.1016/S1470-2045(06)70800-2.
Article
PubMed
Google Scholar
Johnson KR, Freemantle N, Anthony DM, Lassere MN: LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE). J Clin Epidemiol. 2009, 62: 328-336. 10.1016/j.jclinepi.2008.06.004.
Article
PubMed
Google Scholar
Temple R: Are surrogate markers adequate to assess cardiovascular disease drugs?. JAMA. 1999, 282: 790-795. 10.1001/jama.282.8.790.
Article
CAS
PubMed
Google Scholar
Lesko LJ, Atkinson AJ: Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annual Review of Pharmacology & Toxicology. 2001, 41: 347-366. 10.1146/annurev.pharmtox.41.1.347.
Article
CAS
Google Scholar
Desai M, Stockbridge N, Temple R: Blood pressure as an example of a biomarker that functions as a surrogate. AAPS Journal. 2006, 8: E146-152. 10.1208/aapsj080117.
Article
CAS
PubMed
PubMed Central
Google Scholar
Turnbull F, Kengne AP, MacMahon S: Blood pressure and cardiovascular disease: tracing the steps from Framingham. Prog Cardiovasc Dis. 2010, 53: 39-44. 10.1016/j.pcad.2010.03.002.
Article
PubMed
Google Scholar
Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001, 358: 1305-1315. 10.1016/S0140-6736(01)06411-X.
Article
CAS
PubMed
Google Scholar
Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S: Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008, 336: 1121-1123.
Article
PubMed Central
Google Scholar
Law MR, Morris JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009, 338: b1665-10.1136/bmj.b1665.
Article
CAS
PubMed
PubMed Central
Google Scholar
Willett W: An overview of issues related to the correction of non-differential exposure measurement error in epidemiologic studies. Statistics in Medicine. 1989, 8: 1031-1040. 10.1002/sim.4780080903.
Article
CAS
PubMed
Google Scholar
Gillard J, Iles T: Methods of fitting straight lines where both variables are subject to measurement error. Current Clinical Pharmacology. 2009, 4: 164-171. 10.2174/157488409789375302.
Article
PubMed
Google Scholar
Tobin J: Estimation of relationships for limited dependent variables. Econometrica. 1958, 26: 24-36. 10.2307/1907382.
Article
Google Scholar
Roystan P, Altman DG: Regression using fractional polynomials of continuous variables: Parsimonious parametric modelling. Applied Statistics. 1994, 43: 429-467. 10.2307/2986270.
Article
Google Scholar
Altman DG: Practical statistics for medical research. 1991, London: Chapman and Hall
Google Scholar
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990, 335: 827-838. 10.1016/0140-6736(90)90944-Z.
Article
CAS
PubMed
Google Scholar
Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O' Brien E, Ostergren J, ASCOT Investigators: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005, 366: 895-906. 10.1016/S0140-6736(05)67185-1.
Article
PubMed
Google Scholar
Anonymous: Report by the Management Committee: The Australian therapeutic trial in mild hypertension. Lancet. 1980, 1: 1261-1267.
Google Scholar
The IPPPSH Collaborative Group: Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens. 1985, 3: 379-392.
Article
Google Scholar
Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed). 1985, 291: 97-104.
Article
Google Scholar
Coope J, Warrender TS: Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986, 293: 1145-1151. 10.1136/bmj.293.6555.1145.
Article
CAS
Google Scholar
SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991, 265: 3255-3264.
Article
Google Scholar
Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991, 338: 1281-1285. 10.1016/0140-6736(91)92589-T.
Article
CAS
PubMed
Google Scholar
Medical Research Council Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992, 304: 405-412.
Article
Google Scholar
PATS Collaborating Group: Post-stroke antihypertensive treatment study. a preliminary result. Chin Med J (Engl). 1995, 108: 710-717.
Google Scholar
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O' Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. the systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet. 1997, 350: 757-764. 10.1016/S0140-6736(97)05381-6.
Article
CAS
PubMed
Google Scholar
Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000, 102: 1503-1510. 10.1161/01.CIR.102.13.1503.
Article
CAS
PubMed
Google Scholar
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001, 358: 1033-1041.
Article
Google Scholar
Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003, 362: 782-788.
Article
CAS
PubMed
Google Scholar
Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21: 875-886. 10.1097/00004872-200305000-00011.
Article
CAS
PubMed
Google Scholar
Bulpitt CJ, Beckett NS, Cooke J, Dumitrascu DL, Gil-Extremera B, Nachev C, Nunes M, Peters R, Staessen JA, Thijs L, Hypertension in the Very Elderly Trial Working Group: Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003, 21: 2409-2417. 10.1097/00004872-200312000-00030.
Article
CAS
PubMed
Google Scholar
Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL, PEACE Trial Investigators: Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004, 351: 2058-2068.
Article
CAS
PubMed
Google Scholar
Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S, Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators: Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet. 2004, 364: 849-857. 10.1016/S0140-6736(04)16980-8.
Article
CAS
PubMed
Google Scholar
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P: Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008, 372: 1174-1183.
Article
Google Scholar
Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ, HYVET Study Group: Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008, 358: 1887-1898. 10.1056/NEJMoa0801369.
Article
CAS
PubMed
Google Scholar
Rose GA, Holland WW, Crowley EA: A sphygmomanometer for epidemiologists. Lancet. 1964, 1: 296-300.
Article
CAS
PubMed
Google Scholar
Conway J: Blood pressure and heart rate variability. J Hypertens. 1986, 4: 261-263. 10.1097/00004872-198606000-00001.
Article
CAS
PubMed
Google Scholar
Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A: Effects of blood-pressure measurement by the doctor on patient' s blood pressure and heart rate. Lancet. 1983, 2: 695-698.
Article
CAS
PubMed
Google Scholar
Hebel JR, Apostolides AY, Dischinger P, Entwisle G, Su S: Within-person variability in diastolic blood pressure for a cohort of normotensives. J Chronic Dis. 1980, 33: 745-750. 10.1016/0021-9681(80)90062-4.
Article
CAS
PubMed
Google Scholar
Gerin W, Rosofsky M, Pieper C, Pickering TG: A test of reproducibility of blood pressure and heart rate variability using a controlled ambulatory procedure. J Hypertens. 1993, 11: 1127-1131. 10.1097/00004872-199310000-00018.
Article
CAS
PubMed
Google Scholar
Giaconi S, Palombo C, Genovesi-Ebert A, Marabotti C, Volterrani D, Ghione S: Long-term reproducibility and evaluation of seasonal influences on blood pressure monitoring. J Hypertens Suppl. 1988, 6: S64-66.
Article
CAS
PubMed
Google Scholar
Armitage P, Blendis LN, Smyllie HC: The measurement of observer agreement in recoding of signs. J R Statist Soc A. 1966, 129: 98-109. 10.2307/2343899.
Article
Google Scholar
Gardner MJ, Heady JA: Some effects of within-person variability in epidemiological studies. J Chronic Dis. 1973, 26: 781-795. 10.1016/0021-9681(73)90013-1.
Article
Google Scholar
Muntner P, Joyce C, Levian E, Holt E, Shimbo D, Webber LS, Opaaril S, Re R, Krousel-Wood M: Reproducibilitiy of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011, 29: 2332-2338. 10.1097/HJH.0b013e32834cf213.
Article
CAS
PubMed
PubMed Central
Google Scholar
Skirton H, Chamberlain W, Lawson C, Ryan H, Young E: A systematic review of variability and reliability of manual and automated blood pressure readings. J Clin Nurs. 2011, 20: 602-14. 10.1111/j.1365-2702.2010.03528.x.
Article
PubMed
Google Scholar
Rothwell PM: Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010, 375: 938-948. 10.1016/S0140-6736(10)60309-1.
Article
PubMed
Google Scholar
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R: Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999, 150: 341-353. 10.1093/oxfordjournals.aje.a010013.
Article
CAS
PubMed
Google Scholar
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990, 335: 765-774. 10.1016/0140-6736(90)90878-9.
Article
CAS
PubMed
Google Scholar
Li Y, Taylor JM, Elliott MR: A Bayesian approach to surrogacy assessment using principal stratification in clinical trials. Biometrics. 2010, 66: 523-531. 10.1111/j.1541-0420.2009.01303.x.
Article
PubMed
Google Scholar
Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O' Callaghan CJ, Francini G, Grothey A, O' Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005, 23: 8664-8670. 10.1200/JCO.2005.01.6071.
Article
PubMed
Google Scholar
Buyse M: Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials. Cancer Journal. 2009, 15: 421-425. 10.1097/PPO.0b013e3181b9c602.
Article
Google Scholar
Michiels S, Le Maitre A, Buyse M, Burzykowski T, Maillard E, Bogaerts J, Vermorken JB, Budach W, Pajak TF, Ang KK, Bourhis J, Pignon JP, MARCH and MACH-NC Collaborative Groups: Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncology. 2009, 10: 341-50. 10.1016/S1470-2045(09)70023-3.
Article
PubMed
Google Scholar
Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003, 326: 1427-
Article
CAS
PubMed
PubMed Central
Google Scholar
Boissel JP, Gueyffier F, Boutitie F, Pocock S, Fagard R: Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments. Fundamental & Clinical Pharmacology. 2005, 19: 579-584. 10.1111/j.1472-8206.2005.00356.x.
Article
CAS
Google Scholar
Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, Lambers Heerspink HJ, Perkovic V, Huxley R, Arima H, Patel A, Chalmers J, Woodward M, MacMahon S, Neal B, Blood Pressure Lowering Treatment Trialists' Collaboration: The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011, 29: 4-16. 10.1097/HJH.0b013e32834000be.
Article
CAS
PubMed
Google Scholar
Boutitie F, Gueyffier F, Pocock SJ, Boissel JP: Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials. Stat Med. 1998, 17: 2883-2903. 10.1002/(SICI)1097-0258(19981230)17:24<2883::AID-SIM900>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
Webb AJ, Fischer U, Mehta Z, Rothwell PM: Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010, 375: 906-915. 10.1016/S0140-6736(10)60235-8.
Article
CAS
PubMed
Google Scholar
Rothwell PM, Howard SC, Dolan E, O' Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010, 375: 895-905. 10.1016/S0140-6736(10)60308-X.
Article
PubMed
Google Scholar
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998, 351: 1755-1762. 10.1016/S0140-6736(98)04311-6.
Article
CAS
PubMed
Google Scholar
HOT Study Group: The Hypertension Optimal Treatment Study (the HOT Study). Blood Press. 1993, 2: 62-68.
Article
Google Scholar
Johnson K: Strengths and weaknesses of renal markers as risk factors and surrogate markers. Kidney Int. 2011, 79: 1272-1274. 10.1038/ki.2011.61.
Article
PubMed
Google Scholar